BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

AlloCure Inc. 

615 Arapeen Drive
Suite 300
Salt Lake City  Utah  84108  U.S.A.
Phone: 801-583-8450 Fax: 801-583-8452


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





 Company News
AlloCure Inc. Begins Phase 2 Clinical Trial in Acute Kidney Injury 9/4/2012 10:01:06 AM    More...
AlloCure Inc. Raises $25 Million Series B Venture Financing 4/2/2012 7:21:35 AM    More...
AlloCure Inc.’s Investigational Treatment for Acute Kidney Injury Receives Fast Track Designation by FDA 1/5/2012 7:20:56 AM    More...
AlloCure Inc. Stem Cell Trial Provides Glimpse of Promising Treatment for Kidney Damage 11/18/2011 8:15:03 AM    More...
AlloCure Inc. Presents Safety and Preliminary Efficacy of AC607 for the Treatment of Acute Kidney Injury at American Society of Nephrology 11/14/2011 7:14:31 AM    More...
AlloCure Inc. Appoints Kevin J. Heyeck as Chief Business Officer 2/14/2011 8:47:40 AM    More...
AlloCure Inc. Names Robert M. Brenner, M.D. Chief Executive Officer 7/6/2010 11:43:29 AM    More...
AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 7/2/2008 11:00:45 AM    More...

//-->